Vaccine adjuvancy: a new potential area of development for GM-CSF.
Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
M
M
Taglietti
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000368:Aged; D000818:Animals; D000938:Antigen-Presenting Cells / Q000187:drug effects / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage; D014612:Vaccines / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D011994:Recombinant Proteins; D014612:Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor